Can I read Abushamat Et Al 2024 Rosiglitazone Improves Insulin Resistance But Does Not Improve Exercise Capacity in Individuals on EtoBox?

Abushamat Et Al 2024 Rosiglitazone Improves Insulin Resistance But Does Not Improve Exercise Capacity in Individuals by 2307240010 MUHAMMAD MIFTAH FAUZI is a document available to read on EtoBox.

What is Abushamat Et Al 2024 Rosiglitazone Improves Insulin Resistance But Does Not Improve Exercise Capacity in Individuals about?

A randomized clinical study investigated the effects of rosiglitazone (RO) on insulin resistance (IR) and exercise capacity in individuals with impaired glucose tolerance (IGT). While RO significantly improved IR and glycemic measures, it did not enhance exercise capacity or markers of cardiovascular disease risk over an 18-month period. The findings suggest that factors other than insulin sensitivity may affect exercise capacity in this population, warranting further research.

Author

2307240010 MUHAMMAD MIFTAH FAUZI

Language

EN